BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15101717)

  • 1. Autologous bone marrow transplantation for marginal zone non-Hodgkin's lymphoma.
    Brown JR; Gaudet G; Friedberg JW; Neuberg D; Mauch P; Kutok JL; Takvorian T; Fisher DC; Gribben JG; Kim H; Nadler LM; Freedman AS
    Leuk Lymphoma; 2004 Feb; 45(2):315-20. PubMed ID: 15101717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies.
    Friedberg JW; Neuberg D; Gribben JG; Mauch P; Anderson KC; Soiffer RJ; Takvorian T; Fisher DC; Schlossman R; Jallow H; Kuhlman C; Ritz J; Freedman AS
    Biol Blood Marrow Transplant; 1999; 5(4):262-8. PubMed ID: 10465106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemoradiotherapy and anti-B-cell monoclonal antibody-purged autologous bone marrow transplantation in mantle-cell lymphoma: no evidence for long-term remission.
    Freedman AS; Neuberg D; Gribben JG; Mauch P; Soiffer RJ; Fisher DC; Anderson KC; Andersen N; Schlossman R; Kroon M; Ritz J; Aster J; Nadler LM
    J Clin Oncol; 1998 Jan; 16(1):13-8. PubMed ID: 9440717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of external beam radiation therapy prior to autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma.
    Friedberg JW; Neuberg D; Monson E; Jallow H; Nadler LM; Freedman AS
    Biol Blood Marrow Transplant; 2001; 7(8):446-53. PubMed ID: 11569890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma.
    Verdonck LF; Dekker AW; Lokhorst HM; Petersen EJ; Nieuwenhuis HK
    Blood; 1997 Nov; 90(10):4201-5. PubMed ID: 9354692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous stem-cell transplantation for poor-risk and relapsed intermediate- and high-grade non-Hodgkin's lymphoma.
    Nademanee A; Molina A; Dagis A; Snyder DS; O'Donnell MR; Parker P; Stein A; Smith E; Planas I; Kashyap A; Spielberger R; Fung H; Krishnan A; Bhatia R; Wong KK; Somlo G; Margolin K; Chow W; Sniecinski I; Vora N; Slovak M; Niland JC; Forman SJ
    Clin Lymphoma; 2000 Jun; 1(1):46-54. PubMed ID: 11707813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial.
    Stiff PJ; Dahlberg S; Forman SJ; McCall AR; Horning SJ; Nademanee AP; Blume KG; LeBlanc M; Fisher RI
    J Clin Oncol; 1998 Jan; 16(1):48-55. PubMed ID: 9440722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
    de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
    Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High dose chemotherapy with thiotepa, mitoxantrone and carboplatin (TMJ) followed by autologous stem cell support in 100 consecutive lymphoma patients in a single centre: analysis of efficacy, toxicity and prognostic factors.
    Waheed F; Kancherla R; Seiter K; Liu D; Qureshi Z; Hoang A; Ahmed T
    Leuk Lymphoma; 2004 Nov; 45(11):2253-9. PubMed ID: 15512814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation in non-Hodgkin's lymphoma patients at high risk of bone marrow involvement.
    Bird JM; Luger S; Mangan P; Edelstein M; Silberstein L; Powlis W; Ball J; Schultz DJ; Stadtmauer EA
    Bone Marrow Transplant; 1996 Aug; 18(2):309-13. PubMed ID: 8864439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of interleukin-2 in non-Hodgkin's lymphoma following transplantation of interleukin-2-activated autologous bone marrow or stem cells.
    van Besien K; Margolin K; Champlin R; Forman S
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S54-8. PubMed ID: 9457395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis.
    Takvorian T; Canellos GP; Ritz J; Freedman AS; Anderson KC; Mauch P; Tarbell N; Coral F; Daley H; Yeap B
    N Engl J Med; 1987 Jun; 316(24):1499-505. PubMed ID: 3295542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term survival after autologous bone marrow transplantation for follicular lymphoma in first remission.
    Brown JR; Feng Y; Gribben JG; Neuberg D; Fisher DC; Mauch P; Nadler LM; Freedman AS
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1057-65. PubMed ID: 17697968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous bone marrow transplantation in non-Hodgkin's lymphoma: monoclonal antibodies plus complement for ex vivo marrow treatment.
    Hurd DD; LeBien TW; Lasky LC; Haake RJ; Ramsay NK; Kim TH; Levine EG; McGlave PB; Bloomfield CD; Peterson BA
    Am J Med; 1988 Dec; 85(6):829-34. PubMed ID: 3057901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged disease-free survival after autografting for chemosensitive non-bulky low grade non-Hodgkin's Lymphoma.
    Grigg A; Clarke K; Szer J
    Leuk Lymphoma; 2000 Oct; 39(3-4):283-90. PubMed ID: 11342308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.
    Dann EJ; Daugherty CK; Larson RA
    Bone Marrow Transplant; 1997 Sep; 20(5):369-74. PubMed ID: 9339751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
    Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
    J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest.
    Sharp JG; Kessinger A; Mann S; Crouse DA; Armitage JO; Bierman P; Weisenburger DD
    J Clin Oncol; 1996 Jan; 14(1):214-9. PubMed ID: 8558200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma.
    Bernard M; Dauriac C; Drénou B; Leberre C; Branger B; Fauchet R; Le Prisé PY; Lamy T
    Bone Marrow Transplant; 1999 Feb; 23(4):329-33. PubMed ID: 10100576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.
    Freedman AS; Takvorian T; Anderson KC; Mauch P; Rabinowe SN; Blake K; Yeap B; Soiffer R; Coral F; Heflin L
    J Clin Oncol; 1990 May; 8(5):784-91. PubMed ID: 2332768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.